Article

Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma.

2024-05-24

Abstract excerpt

Personalized cancer vaccines have emerged as a promising avenue for cancer treatment or prevention strategies. This approach targets the specific genetic alterations in individual patient’s tumors, offering a more personalized and effective treatment option. Previous studies have shown that generalized peptide vaccines targeting a limited scope of gene mutations are ineffective, emphasizing the need for pers...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dd6fd0bf-1c2a-5848-a2f5-7d5830229e9d
DOI: 10.20944/preprints202405.1612.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Novel Methodology for the Design of Personalized Cancer Vaccine Targeting Neoantigens: Application to Pancreatic Ductal Adenocarcinoma.DOI 10.20944/preprints202405.1612.v1Read

Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapySemantic proximity Read

Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer.Semantic proximity Read

A Peptide-Based Neoantigen Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard TreatmentSemantic proximity Read

Automating neoantigen selection for personalized cancer vaccine designSemantic proximity Read

Bioinformatics for Cancer Immunotherapy.Semantic proximity Read

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigensSemantic proximity Read

Harnessing Tumor-Specific Transcript Diversity Uncovers a Shared Neoantigen Reservoir for Pancreatic Ductal AdenocarcinomaSemantic proximity Read

Personalized medicine in pancreatic cancer: Harnessing the potential of mRNA vaccinesSemantic proximity Read

<i>In vitro</i> validation of neoantigen prediction algorithm for developing personalized cancer vaccine therapySemantic proximity Read

Vaxrank: A computational tool for designing personalized cancer vaccinesSemantic proximity Read

Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialSemantic proximity Read

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development.Semantic proximity Read